View all newsletters
Receive our newsletter - data, insights and analysis delivered to you
  1. Deals Analysis
October 25, 2021

Medical Devices industry cross border deals total $1.2bn globally in September 2021

Total medical devices industry cross border deals worth $1.2bn were announced globally for September 2021, with the $538m acquisition of Itamar Medical being the sector’s biggest investment, according to GlobalData’s deals database.

  • Embed this chart

    Embed this chart into your website

    Copy and paste the image source into your website to display the chart.

The value marked a decrease of 90.9% over the previous month of $13.23bn and a drop of 82.3% when compared with the last 12-month average of $6.84bn.

In terms of number of cross border deals, the sector saw a drop of 26.79% with 41 deals in September 2021 when compared to the last 12-month average of 56 deals.

In value terms, Middle East and Africa led the activity with cross border deals worth $538m in September 2021.

medical devices industry cross border deals in September 2021: Top deals

The top five cross border deals accounted for 74.7% of the overall value during September 2021.

The combined value of the top five cross border deals stood at $903m, against the overall value of $1.2bn recorded for the month.

The top five medical devices industry cross border deals of September 2021 tracked by GlobalData were:

1) Zoll Medical $538m acquisition deal with Itamar Medical

2) The $150m venture financing of Mammoth Biosciences by Decheng Capital,Foresite Capital Management,Greenspring Associates,Mayfield Fund,NFX partners,Plum Alley Investments,Redmile Group,Senator Investment Group and Sixth Street Partners

3) BlackRock,Endeavour Vision,Farallon Capital Management,Marshall Wace,MVM Partners,Novo Ventures (US),RTW Investments,Soleus Capital Management,venBio and Vivo Capital $102m venture financing deal with INBRACE

4) The $58m venture financing of Owlstone Medical by Horizon Ventures

5) Arboretum Ventures,Coloplast,H2Oey Ventures,Solas Bioventures and Tonkawa $55m venture financing deal with Francis Medical

Related Companies

Verdict deals analysis methodology

This analysis considers only announced and completed cross border deals from the GlobalData financial deals database and excludes all terminated and rumoured deals. Country and industry are defined according to the headquarters and dominant industry of the target firm. The term ‘acquisition’ refers to both completed deals and those in the bidding stage.

GlobalData tracks real-time data concerning all merger and acquisition, private equity/venture capital and asset transaction activity around the world from thousands of company websites and other reliable sources.

More in-depth reports and analysis on all reported deals are available for subscribers to GlobalData’s deals database.

Topics in this article:
NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. The top stories of the day delivered to you every weekday. A weekly roundup of the latest news and analysis, sent every Friday. The medical device industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy


Thank you for subscribing to Medical Device Network